【摘要】：目的:通過(guò)研究益氣化痰活血方對(duì)中醫(yī)氣虛痰阻血瘀型不穩(wěn)定心絞痛患者的血清TNF-α、IL-6、hs-CRP等的炎癥因子影響,來(lái)探討益氣化痰活血方對(duì)冠脈不穩(wěn)定斑塊的抗炎穩(wěn)斑效應(yīng)。方法:采取臨床觀察的辦法,制定并分析臨床病例報(bào)告表,選擇2014年10月~2015年10月在河南中醫(yī)藥大學(xué)第一附屬醫(yī)院老年病科和心內(nèi)科的門診及住院且確診為中醫(yī)診斷:胸痹氣虛痰阻血瘀證;西醫(yī)診斷:冠心病不穩(wěn)定型心絞痛的患者,共計(jì)60例。將患者按隨機(jī)數(shù)字表法隨機(jī)分為2組,對(duì)照組進(jìn)行常規(guī)的抗血小板聚集、抗凝、抗缺血藥物治療并加服阿托伐他汀鈣片20mg/d治療。觀察組在上述西藥治療的基礎(chǔ)上加用中藥復(fù)方益氣化痰活血方。觀察兩組患者的中西醫(yī)療效、血脂和血清炎癥因子TNF-a、IL-6、hs-CRP水平,多排冠脈螺旋CT檢測(cè)斑塊平均CT值、斑塊最小CT值及斑塊體積變化。通過(guò)統(tǒng)計(jì)軟件包SPSS18.0建立數(shù)據(jù)庫(kù),進(jìn)行數(shù)據(jù)管理與分析,并最終得出結(jié)果。結(jié)果:1.治療前,兩組患者各檢測(cè)指標(biāo)并無(wú)統(tǒng)計(jì)學(xué)差異(P0.05);2.治療后,兩組患者的中西醫(yī)療效、血脂、TNF-α、IL-6、hs-CRP,冠脈斑塊指標(biāo)與治療前比較,具有統(tǒng)計(jì)學(xué)差異(P0.05);3.治療后,觀察組與對(duì)照組比較:(1)觀察組心絞痛癥狀改善顯效16例,有效13例,無(wú)效1例,總有效率96.67%,對(duì)照組顯效10例,有效12例,無(wú)效8例,總有效率73.33%;中醫(yī)證候積分改善方面,觀察組79.32%,對(duì)照組53.28%;均具有顯著差異(P0.05),觀察組的改善均優(yōu)于對(duì)照組。心電圖療效方面,兩組比較無(wú)顯著差異(P0.05);住院期間兩組均未出現(xiàn)心絞痛癥狀加重的病人。(2)血脂:觀察組的TC、TG、LDL-C明顯低于對(duì)照組,HDL-C卻明顯高于對(duì)照組,并具有統(tǒng)計(jì)學(xué)差異(P0.05);(3)血清炎癥因子:觀察組的TNF-α、IL-6、hs-CRP水平明顯低于對(duì)照組,并具有統(tǒng)計(jì)學(xué)差異(P0.05);(4)多排冠脈螺旋CT:平均CT值、最小CT值:組內(nèi)比較,觀察組斑塊治療后較治療前顯著增加(P0.05),對(duì)照組僅觀察到有增加的態(tài)勢(shì),但尚無(wú)顯著差異(P0.05);組間比較:治療后兩組斑塊平均CT值、斑塊最小CT值有顯著差異,觀察組較對(duì)照組顯著增加(P0.05)。斑塊體積:兩組治療前后比較可見縮小,但均未達(dá)到顯著水平(P0.05)。結(jié)論:益氣化痰活血方與阿托伐他汀聯(lián)合能夠降低不穩(wěn)定型心絞痛患者的血清TNF-a、IL-6、hs-CRP等炎癥的因子水平,可以更優(yōu)地發(fā)揮出抗炎癥免疫反應(yīng),從而提高了冠脈不穩(wěn)定斑塊的穩(wěn)定性;不穩(wěn)定型心絞痛患者的心肌缺血癥狀得到更好的緩解,進(jìn)而改善了不穩(wěn)定型心絞痛的臨床預(yù)后;二者具有協(xié)同的治療作用,可以為臨床治療冠脈不穩(wěn)定斑塊,降低不穩(wěn)定型心絞痛患者的惡性心血管事件的發(fā)生率提供較為可靠的理論依據(jù)。
[Abstract]:Objective: to study the effect of Yiqi Huatan Huoxue recipe on inflammatory factors of serum TNF- 偽 and IL-6 hs-CRP in patients with unstable angina pectoris of Qi deficiency and phlegm obstruction and blood stasis type, so as to explore the anti-inflammatory and stable plaque effect of Yiqi Huatan Huoxue recipe on unstable plaque of coronary artery. Methods: clinical observation method was adopted to make and analyze the clinical case report form. From October 2014 to October 2015, the outpatients of geriatrics and cardiology in the first affiliated Hospital of Henan University of traditional Chinese Medicine were selected and diagnosed with TCM diagnosis: Qi deficiency of chest obstruction of phlegm and blood stasis syndrome; Western medicine diagnosis: patients with unstable angina pectoris of coronary heart disease. A total of 60 cases. Patients were randomly divided into two groups according to random digital table. The control group was treated with routine antiplatelet aggregation, anticoagulant, antiischemic drugs and Atto vastatin calcium tablet 20mg/d. Observation group on the basis of the above-mentioned western medicine treatment plus Chinese medicine compound Yiqi Huatan Huoxue prescription. The therapeutic effect of traditional Chinese and western medicine, the level of serum lipid and serum inflammatory factor TNF-a, IL-6hs-CRP, the mean CT value of plaque, the minimum CT value of plaque and the volume of plaque were detected by multi-slice spiral CT. The database is established by SPSS18.0, and the data is managed and analyzed. Finally, the results are obtained. The result is 1: 1. Before treatment, there was no statistical difference between the two groups (P0.05). After treatment, the therapeutic effect of traditional Chinese and western medicine, TNF- 偽 TNF- 偽 IL-6hs-CRPand coronary plaque index were significantly different between the two groups (P0.05). After treatment, the observation group compared with the control group: (1) the angina pectoris in the observation group improved significantly in 16 cases, effective in 13 cases, ineffective in 1 case, the total effective rate was 96.677.67, the control group had remarkable effect in 10 cases, effective in 12 cases, ineffective in 8 cases. The total effective rate was 73.33; the improvement of TCM syndromes integral, observation group 79.32, control group 53.28; there were significant differences (P0.05), the observation group is better than the control group. There was no significant difference in the effect of electrocardiogram between the two groups (P0.05); in the two groups, there was no exacerbation of angina pectoris during hospitalization. (2) Blood lipids: TCU TGG LDL-C in the observation group was significantly lower than that in the control group, but significantly higher than that in the control group. The levels of TNF- 偽 IL-6hs-CRP in the observation group were significantly lower than those in the control group (P0.05); (4). The plaque in the observation group increased significantly after treatment (P0.05), but there was no significant difference in the control group (P0.05). Comparison between the two groups: after treatment, the mean CT value of plaque and the minimum CT value of plaque were significantly different. Compared with the control group, the observation group significantly increased (P0.05). Plaque volume: two groups before and after treatment can be seen reduced, but did not reach a significant level (P0.05). Conclusion: the combination of Yiqi Huatan Huoxue recipe and Atto vastatin can reduce the level of inflammatory factors such as TNF-aji-IL-6hs-CRP in serum of patients with unstable angina pectoris, and can play a better role in anti-inflammatory immune response, thus improving the stability of unstable plaque of coronary artery. The symptoms of myocardial ischemia in patients with unstable angina pectoris were better alleviated, and the clinical prognosis of unstable angina pectoris was improved. Reducing the incidence of malignant cardiovascular events in patients with unstable angina pectoris provides a reliable theoretical basis.
【學(xué)位授予單位】：河南中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R259

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 劉國(guó)麗;;化痰活血法治療2型糖尿病30例臨床研究[J];國(guó)醫(yī)論壇;2010年01期

2 周福;史嵩海;;化痰活血定眩湯治療椎基底動(dòng)脈供血不足性眩暈[J];吉林中醫(yī)藥;2013年07期

3 程運(yùn)文;;曹鳴高應(yīng)用化痰活血八法經(jīng)驗(yàn)[J];江蘇中醫(yī);1989年07期

4 李五江;王守富;;化痰活血法治療冠心病研究進(jìn)展[J];中醫(yī)研究;2014年03期

5 張偉生;;化痰活血法治療缺血性中風(fēng)急性期的臨床研究[J];中國(guó)醫(yī)藥指南;2014年11期

6 陳光明;化痰活血法在幾種心臟病治療中的運(yùn)用[J];四川中醫(yī);2004年07期

7 馮建華;徐云生;;化痰活血法治療2型糖尿病30例臨床研究[J];中醫(yī)雜志;2004年03期

8 于蘊(yùn)奇,丁加森;化痰活血法治療椎-基底動(dòng)脈供血不足性眩暈臨床觀察[J];吉林中醫(yī)藥;2005年07期

9 張建明;;化痰活血法在神志病變中的應(yīng)用和體會(huì)[J];山西中醫(yī);1991年05期

10 杜長(zhǎng)海;熄風(fēng)化痰活血法治療眩暈80例臨床觀察[J];北京中醫(yī);1997年05期

相關(guān)會(huì)議論文 前7條

1 馮建華;;化痰活血法治療Ⅱ型糖尿病胰島素抵抗的臨床研究[A];2011年中華名中醫(yī)論壇暨發(fā)揮中西醫(yī)優(yōu)勢(shì)防治腫瘤高峰論壇論文集[C];2011年

2 陶憲印;陶憲武;;化痰活血法治療2型糖尿病臨床觀察[A];糖尿病中醫(yī)研究進(jìn)展——全國(guó)第六次中醫(yī)糖尿病學(xué)術(shù)會(huì)議論文集[C];2000年

3 馮建華;徐云生;;化痰活血法改善2型糖尿病胰島素抵抗的臨床研究[A];第七次全國(guó)中醫(yī)糖尿病學(xué)術(shù)大會(huì)論文匯編[C];2003年

4 徐云生;;化痰活血降糖方改善2型糖尿病胰島素抵抗的臨床觀察[A];糖尿病（消渴�。┲嗅t(yī)診治薈萃——全國(guó)第五次中醫(yī)糖尿病學(xué)術(shù)大會(huì)論文集[C];1999年

5 吳雄志;;溫陽(yáng)化痰活血法治療惡性腫瘤研究[A];2010中國(guó)醫(yī)師協(xié)會(huì)中西醫(yī)結(jié)合醫(yī)師大會(huì)摘要集[C];2010年

6 石冬霞;左新河;;化痰活血消突湯治療甲亢性突眼療效觀察[A];5TH全國(guó)中西醫(yī)結(jié)合內(nèi)分泌代謝病學(xué)術(shù)大會(huì)暨糖尿病論壇論文集[C];2012年

7 李振中;董志;丁學(xué)屏;尹翠梅;郭俊杰;南征;;氣虛濁留[A];第八次全國(guó)中醫(yī)藥傳承創(chuàng)新與發(fā)展學(xué)術(shù)研討會(huì)論文集[C];2009年

相關(guān)重要報(bào)紙文章 前1條

1 ;益氣化痰活血法配合氧療能有效緩解慢性肺心病癥狀[N];中國(guó)中醫(yī)藥報(bào);2004年

相關(guān)博士學(xué)位論文 前2條

1 葉勇;化痰活血方對(duì)高脂血癥大鼠降脂作用及其機(jī)理的實(shí)驗(yàn)研究[D];湖北中醫(yī)學(xué)院;2004年

2 楊瀟;益氣化痰活血方對(duì)NOD.H-2~(h4)小鼠甲狀腺Th17細(xì)胞分化調(diào)控的影響[D];遼寧中醫(yī)藥大學(xué);2014年

相關(guān)碩士學(xué)位論文 前10條

1 莊淑涵;益氣化痰活血方治療氣虛痰瘀型老年穩(wěn)定性心絞痛的臨床觀察[D];云南中醫(yī)學(xué)院;2016年

2 何麗霞;化痰活血方和梓醇拮抗哮喘小鼠炎癥和黏蛋白MUC5AC機(jī)制的研究[D];暨南大學(xué);2016年

3 朱志剛;化痰活血方治療高脂血癥的理論與藥效研究[D];南京中醫(yī)藥大學(xué);2016年

4 賈景香;益氣化痰活血方對(duì)冠脈不穩(wěn)定斑塊的作用及對(duì)血清TNF-α、IL-6、hs-CRP影響的研究[D];河南中醫(yī)藥大學(xué);2016年

5 代會(huì)容;化痰活血方對(duì)動(dòng)脈粥樣硬化炎癥反應(yīng)及其相關(guān)因子的影響[D];湖北中醫(yī)學(xué)院;2009年

6 龍?jiān)?化痰活血法治療不穩(wěn)定性心絞痛炎癥機(jī)制的臨床研究[D];湖南中醫(yī)藥大學(xué);2005年

7 張芝芝;化痰活血方治療穩(wěn)定型心絞痛的臨床研究[D];山東中醫(yī)藥大學(xué);2013年

8 單麗囡;化痰活血法對(duì)慢性阻塞性肺疾病穩(wěn)定期患者生存質(zhì)量影響的臨床研究[D];廣州中醫(yī)藥大學(xué);2005年

9 顧佳;化痰活血法結(jié)合單硝酸異山梨酯治療冠心病穩(wěn)定型心絞痛的臨床研究[D];南京中醫(yī)藥大學(xué);2011年

10 黃慧婷;化痰活血法治療慢性阻塞性肺疾病急性加重期患者臨床觀察及其對(duì)血液流變學(xué)影響[D];廣州中醫(yī)藥大學(xué);2007年

，

本文編號(hào)：2190984